跳至主要内容
临床试验/NL-OMON49134
NL-OMON49134已完成3 期

The inflammatory response of monocytes and neutrophils to Crystals after Low dose colchicine in patients with coronary artery disease - CrystaLo

Radboud Universitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • * Have suffered from type 1 myocardial infarction
  • * Have been clinically stable for at least three months
  • * Provided written informed consent

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • * Age below 18 years or above 80 years
  • * Use of CYP3A4 or P-glycoprotein inhibitors such as macrolids (claritromycin
  • and erytromycin), ciclosporin, ketoconazol, itraconazol, voriconazol, HIV
  • protease inhibitors, calciumchannel antagonists such as verapamil and diltiazem
  • * Women who are pregnant, breast feeding or may be considering pregnancy during
  • the study period or six month after the end of study participation
  • * Male patients who may be considering conceiving during the study period or
  • before six months after the end of study participation
  • * Have renal impairment as evidenced by a serum creatinine >150 *mol/l or eGFR
  • <50mL/min/1.73m2)
  • * Have an elevated inflammatory profile as evidenced by a hsCRP >10mg/l in
  • order to exclude patients with intercurrent (subclinical) infections
  • * Have a moderate to severe hepatic disease
  • * Suffer from pre-existing chronic gastro-intestinal complaints which might
  • obscure signs of colchicine toxicity
  • * Malignant disease in past five years or any medical condition that could
  • interfere with the conduct of the study in the opinion of the investigator.
  • * Chronic or recent (<1 month) infections and/or clinical signs of acute
  • * Suffering from auto-immune / inflammatory diseases
  • * Chronic use of immunosuppressants or anti-inflammatory drugs, including
  • * A history of haematological malignant disease
  • * Recent hospital admission or surgery with general anaesthesia (<3 months)
  • * Previous vaccination within 1 month prior to study entry
  • * Inability or unwillingness to comply with the protocol requirements, or
  • deemed by investigator to be unfit for the study.
  • * Are currently enrolled in a competing trial

研究者

相似试验